|
Volumn 15, Issue 3, 2001, Pages 269-276
|
Review article: Barrett's oesophagus, dysplasia and pharmacologic acid suppression
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CELL DNA;
CYCLOOXYGENASE 2;
LANSOPRAZOLE;
OMEPRAZOLE;
PROSTAGLANDIN E2;
PROTON PUMP INHIBITOR;
RANITIDINE;
BARRETT ESOPHAGUS;
CANCER PREVENTION;
CANCER RISK;
CLINICAL TRIAL;
DYSPLASIA;
ESOPHAGUS CARCINOMA;
ESOPHAGUS PH;
GASTROESOPHAGEAL REFLUX;
HUMAN;
METAPLASIA;
ONCOGENE C ERB;
ONCOGENE C JUN;
ONCOGENE SRC;
PRIORITY JOURNAL;
REVIEW;
RISK MANAGEMENT;
STOMACH ACID SECRETION;
ADENOCARCINOMA;
BARRETT ESOPHAGUS;
CELL DIVISION;
CELL TRANSFORMATION, NEOPLASTIC;
DISEASE PROGRESSION;
EPITHELIUM;
ESOPHAGEAL NEOPLASMS;
GASTRIC ACID;
GASTROESOPHAGEAL REFLUX;
HUMANS;
PROTON PUMPS;
RISK FACTORS;
|
EID: 0035119855
PISSN: 02692813
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1365-2036.2001.00939.x Document Type: Review |
Times cited : (52)
|
References (34)
|